Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Disease area: Airway diseases

Abstract

Metabolomic analysis provides molecular and biochemical profiles of metabolites in different biological fluids.
Objectives: The aim of this study was to assess the potential of exhaled breath condensate (EBC) molecular profiling in discrimination patients with COPD and asthma and healthy subjects.
Methods: Twenty patients with asthma, twenty patients with COPD and thirty healthy control subjects were enrolled in cross-sectional study. Every subject performed spirometry and EBC collection. EBC samples were analyzed by gas chromatography – mass-spectrometry method (GC-MS). EBC profiles from patients with asthma were separated from patients with COPD and from healthy control subjects using an algorithm based on linear methods of pattern recognition theory.
Results: We have detected various profiles of semi-volatile organic compounds (SvOC) in EBC in patients with asthma, COPD and healthy subjects. Mathematical approach to available data revealed 9 SvOC which have been deemed the most appropriate for solving recognition problem (2-phenoxyethanol, decanol-1, ethyl citrate, 2,3–dihydro-1-H-inden-1-on and others). EBC profiles of healthy subjects can be distinguished from patients with asthma with reliability 75%, healthy subjects from COPD patients with reliability 85% and asthma patients from COPD patients with reliability 83%.
Conclusion: Metabolomic analysis of EBC can discriminate patients with asthma and COPD and healthy subjects. We propose that differences in SvOC profiles between asthma and COPD are disease related.

Rating:

Share or cite this content

Citations should be made in the following way:
T. N. Anokhina, E. K. Anaev, A. A. Rodionov, A. I. Revelsky, I. A. Revelsky, V. B. Kudriavtsev, A. G. Chuchalin (Moscow, Russian Federation). Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases. Eur Respir J 2011; 38: Suppl. 55, 4791

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Markers of airway diseases in exhaled breath condensate and their clinical value Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005 Structures of an exhaled breath condensate in lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 525s Year: 2005 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases Source: Annual Congress 2009 - Lung function in adults and children Year: 2009 Inflammatory markers in exhaled breath condensate in bronchiectasis Source: Eur Respir J 2004; 24: Suppl. 48, 707s Year: 2004 Inflammatory markers in exhaled breath condensate of two COPD phenotypes Source: Eur Respir J 2005; 26: Suppl. 49, 260s Year: 2005 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Metabonomics applied to exhaled breath condensate in childhood asthma Source: Eur Respir J 2006; 28: Suppl. 50, 123s Year: 2006 Sensors for detecting pulmonary diseases from exhaled breath Source: Eur Respir Rev, 28 (152) 190011; 10.1183/16000617.0011-2019 Year: 2019